EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Factors associated with corticosteroid therapy failure in HTLV–associated spastic paraparesis in an endemic region of Peru

Raul Montalvo, Lizbeth Lizana-Quispe, Thalia Porta-Quinto, Ciro Rodriguez, Kelina Almora-León, Jenny Julian, Edith Lozano-Orihuela

Microbes, Infection and Chemotherapy · 18.02.2026 · 6 · e2695

DOI: 10.54034/mic.e2695 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbes, Infection and Chemotherapy, online erschienen am 18.02.2026. Verfasst von Raul Montalvo und 6 weiteren Autor:innen. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

HTLV-1/2–associated myelopathy/tropical spastic paraparesis (HAM/TSP) is a chronic progressive myelopathy with variable response to corticosteroids. In endemic regions such as central Peru, evidence on predictors of treatment failure remains limited.

Methods

Analytical cross-sectional study of patients with confirmed HTLV-1/2–associated spastic paraparesis treated with corticosteroids (2018–2024) at a tertiary hospital in Huancayo, Peru. Treatment failure was defined as no improvement or worsening on the Osame Motor Disability Score (OMDS). Sociodemographic data, disease duration, comorbidities, and OMDS were extracted from medical records. Bivariate (chi-square) and multivariable logistic regression analyses were performed (p7 years, comorbidities, and severe disability OMDS >7) were associated with treatment failure. After multivariable adjustment, only severe disability remained independently associated (OR 14.77; 95% CI 2.08–104.93; p=0.007). Disease duration >7 years and comorbidities lost significance (p>0.05).

Conclusions

Severe neurological disability (OMDS >7) is the main independent predictor of corticosteroid treatment failure in HAM/TSP. Baseline functional status appears more relevant than disease duration or sociodemographic factors. Early intervention is needed in advanced cases.

Zitieren

APA

Montalvo, R., Lizana-Quispe, L., Porta-Quinto, T., Rodriguez, C., Almora-León, K., Julian, J., & Lozano-Orihuela, E. (2026). Factors associated with corticosteroid therapy failure in HTLV–associated spastic paraparesis in an endemic region of Peru. Microbes, Infection and Chemotherapy, 6, e2695. https://doi.org/10.54034/mic.e2695

Vancouver

Montalvo R, Lizana-Quispe L, Porta-Quinto T, Rodriguez C, Almora-León K, Julian J, et al. Factors associated with corticosteroid therapy failure in HTLV–associated spastic paraparesis in an endemic region of Peru. Microbes, Infection and Chemotherapy. 2026;6:e2695. doi:10.54034/mic.e2695

BibTeX
@article{Montalvo2026,
  author = {Montalvo, Raul and Lizana-Quispe, Lizbeth and Porta-Quinto, Thalia and Rodriguez, Ciro and Almora-León, Kelina and Julian, Jenny and Lozano-Orihuela, Edith},
  title = {Factors associated with corticosteroid therapy failure in HTLV–associated spastic paraparesis in an endemic region of Peru},
  journal = {Microbes, Infection and Chemotherapy},
  year = {2026},
  volume = {6},
  pages = {e2695},
  doi = {10.54034/mic.e2695}
}
Kostenlos starten →